186 related articles for article (PubMed ID: 16253642)
1. Endothelin antagonism improves hepatic insulin sensitivity associated with insulin signaling in Zucker fatty rats.
Berthiaume N; Carlson CJ; Rondinone CM; Zinker BA
Metabolism; 2005 Nov; 54(11):1515-23. PubMed ID: 16253642
[TBL] [Abstract][Full Text] [Related]
2. Metabolic responses with endothelin antagonism in a model of insulin resistance.
Berthiaume N; Wessale JL; Opgenorth TJ; Zinker BA
Metabolism; 2005 Jun; 54(6):735-40. PubMed ID: 15931607
[TBL] [Abstract][Full Text] [Related]
3. Chronic selective glycogen synthase kinase-3 inhibition enhances glucose disposal and muscle insulin action in prediabetic obese Zucker rats.
Dokken BB; Henriksen EJ
Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E207-13. PubMed ID: 16478771
[TBL] [Abstract][Full Text] [Related]
4. Liver-selective glucocorticoid receptor antagonism decreases glucose production and increases glucose disposal, ameliorating insulin resistance.
Zinker B; Mika A; Nguyen P; Wilcox D; Ohman L; von Geldern TW; Opgenorth T; Jacobson P
Metabolism; 2007 Mar; 56(3):380-7. PubMed ID: 17292727
[TBL] [Abstract][Full Text] [Related]
5. Interactions of exercise training and alpha-lipoic acid on insulin signaling in skeletal muscle of obese Zucker rats.
Saengsirisuwan V; Perez FR; Sloniger JA; Maier T; Henriksen EJ
Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E529-36. PubMed ID: 15068957
[TBL] [Abstract][Full Text] [Related]
6. Insulinotropic agent ID-1101 (4-hydroxyisoleucine) activates insulin signaling in rat.
Broca C; Breil V; Cruciani-Guglielmacci C; Manteghetti M; Rouault C; Derouet M; Rizkalla S; Pau B; Petit P; Ribes G; Ktorza A; Gross R; Reach G; Taouis M
Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E463-71. PubMed ID: 15082420
[TBL] [Abstract][Full Text] [Related]
7. Effect of ginsam, a vinegar extract from Panax ginseng, on body weight and glucose homeostasis in an obese insulin-resistant rat model.
Lim S; Yoon JW; Choi SH; Cho BJ; Kim JT; Chang HS; Park HS; Park KS; Lee HK; Kim YB; Jang HC
Metabolism; 2009 Jan; 58(1):8-15. PubMed ID: 19059525
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance in the Zucker diabetic fatty rat: a metabolic characterisation of obese and lean phenotypes.
Leonard BL; Watson RN; Loomes KM; Phillips AR; Cooper GJ
Acta Diabetol; 2005 Dec; 42(4):162-70. PubMed ID: 16382303
[TBL] [Abstract][Full Text] [Related]
9. Pioglitazone improves insulin signaling defects in skeletal muscle from Wistar fatty (fa/fa) rats.
Hayakawa T; Shiraki T; Morimoto T; Shii K; Ikeda H
Biochem Biophys Res Commun; 1996 Jun; 223(2):439-44. PubMed ID: 8670300
[TBL] [Abstract][Full Text] [Related]
10. Mediation of beta-endorphin in exercise-induced improvement in insulin resistance in obese Zucker rats.
Su CF; Chang YY; Pai HH; Liu IM; Lo CY; Cheng JT
Diabetes Metab Res Rev; 2005; 21(2):175-82. PubMed ID: 15386812
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of antihyperglycemic effects of moxonidine in the obese spontaneously hypertensive Koletsky rat (SHROB).
Ernsberger P; Ishizuka T; Liu S; Farrell CJ; Bedol D; Koletsky RJ; Friedman JE
J Pharmacol Exp Ther; 1999 Jan; 288(1):139-47. PubMed ID: 9862764
[TBL] [Abstract][Full Text] [Related]
12. Ghrelin enhances in vivo skeletal muscle but not liver AKT signaling in rats.
Barazzoni R; Zanetti M; Cattin MR; Visintin L; Vinci P; Cattin L; Stebel M; Guarnieri G
Obesity (Silver Spring); 2007 Nov; 15(11):2614-23. PubMed ID: 18070752
[TBL] [Abstract][Full Text] [Related]
13. Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats.
Minoura H; Takeshita S; Kimura C; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Mutoh S
Diabetes Obes Metab; 2007 May; 9(3):369-78. PubMed ID: 17391165
[TBL] [Abstract][Full Text] [Related]
14. Adipose tissue compensates for defect of phosphatidylinositol 3'-kinase induced in liver and muscle by dietary fish oil in fed rats.
Corporeau C; Foll CL; Taouis M; Gouygou JP; Bergé JP; Delarue J
Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E78-E86. PubMed ID: 16339925
[TBL] [Abstract][Full Text] [Related]
15. Salicylate prevents hepatic insulin resistance caused by short-term elevation of free fatty acids in vivo.
Park E; Wong V; Guan X; Oprescu AI; Giacca A
J Endocrinol; 2007 Nov; 195(2):323-31. PubMed ID: 17951543
[TBL] [Abstract][Full Text] [Related]
16. Ameliorating effect of FK614, a novel nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist, on insulin resistance in Zucker fatty rat.
Minoura H; Takeshita S; Yamamoto T; Mabuchi M; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Ita M; Mutoh S
Eur J Pharmacol; 2005 Sep; 519(1-2):182-90. PubMed ID: 16039648
[TBL] [Abstract][Full Text] [Related]
17. Energy restriction prevents the development of type 2 diabetes in Zucker diabetic fatty rats: coordinated patterns of gene expression for energy metabolism in insulin-sensitive tissues and pancreatic islets determined by oligonucleotide microarray analysis.
Colombo M; Kruhoeffer M; Gregersen S; Agger A; Jeppesen P; Oerntoft T; Hermansen K
Metabolism; 2006 Jan; 55(1):43-52. PubMed ID: 16324918
[TBL] [Abstract][Full Text] [Related]
18. Chronic rosiglitazone treatment restores AMPKalpha2 activity in insulin-resistant rat skeletal muscle.
Lessard SJ; Chen ZP; Watt MJ; Hashem M; Reid JJ; Febbraio MA; Kemp BE; Hawley JA
Am J Physiol Endocrinol Metab; 2006 Feb; 290(2):E251-7. PubMed ID: 16118254
[TBL] [Abstract][Full Text] [Related]
19. Statin modulates insulin signaling and insulin resistance in liver and muscle of rats fed a high-fat diet.
Lalli CA; Pauli JR; Prada PO; Cintra DE; Ropelle ER; Velloso LA; Saad MJ
Metabolism; 2008 Jan; 57(1):57-65. PubMed ID: 18078859
[TBL] [Abstract][Full Text] [Related]
20. Fatty liver and insulin resistance in obese Zucker rats: no role for mitochondrial dysfunction.
Flamment M; Arvier M; Gallois Y; Simard G; Malthièry Y; Ritz P; Ducluzeau PH
Biochimie; 2008 Sep; 90(9):1407-13. PubMed ID: 18534199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
